Cardioembolic and small vessel disease stroke show differences in associations between systemic C3 levels and outcome
about
Complement in the Homeostatic and Ischemic BrainVersatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasisInjury site-specific targeting of complement inhibitors for treating stroke.Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction.The inflammatory effects of TNF-α and complement component 3 on coagulation.
P2860
Cardioembolic and small vessel disease stroke show differences in associations between systemic C3 levels and outcome
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@ast
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@en
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@nl
type
label
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@ast
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@en
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@nl
prefLabel
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@ast
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@en
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@nl
P2093
P2860
P50
P1433
P1476
Cardioembolic and small vessel ...... systemic C3 levels and outcome
@en
P2093
Anna Stokowska
Christina Jern
Katarina Jood
Sandra Olsson
P2860
P304
P356
10.1371/JOURNAL.PONE.0072133
P407
P577
2013-08-20T00:00:00Z